During the past decade, Southpointe-Sanford Medical Center Fargo conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.7% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southpointe-Sanford Medical Center Fargo" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "Wake Forest University Health Sciences" with 5 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southpointe-Sanford Medical Center Fargo" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Canadian Cancer Trials Group (CCTG)" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Southpointe-Sanford Medical Center Fargo" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials), "Invasive Breast Carcinoma" (3 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "Southpointe-Sanford Medical Center Fargo" in a lesser frequency.

Most popular intervention types in "Southpointe-Sanford Medical Center Fargo" are "Drug" (27 trials), "Other" (19 trials), "Biological" (16 trials), "Procedure" (11 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (12 trials), "Questionnaire Administration" (11 trials), "Nivolumab" (7 trials), "Carboplatin" (6 trials) and "Magnetic Resonance Imaging" (6 trials). Other intervention names were less common.

The vast majority of trials in "Southpointe-Sanford Medical Center Fargo" are 33 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Southpointe-Sanford Medical Center Fargo". undefined are not yet recruiting, 30 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Southpointe-Sanford Medical Center Fargo, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southpointe-Sanford Medical Center Fargo, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".